-
公开(公告)号:ES2308990T3
公开(公告)日:2008-12-16
申请号:ES00954975
申请日:2000-08-24
Applicant: TORAY INDUSTRIES
Inventor: NAGASE HIROSHI , ENDO TAKASHI , KAWAMURA KUNIAKI , TANAKA TOSHIAKI , SUZUKI TOMOHIKO , SUZUKI TSUTOMU
IPC: C07D489/06 , A61K31/4738 , A61K31/4745 , A61K31/485 , A61K45/00 , A61P25/04 , C07D471/04 , C07D489/08
Abstract: Utilización de clorhidrato de (-)-17-ciclopropilmetil-3,14Beta-dihidroxi-4,5-alfa-epoxi-6Beta-[N-metil-trans-3-(3-furil) acrilamido]morfinano para la fabricación de un medicamento para el dolor neuropático.
-
公开(公告)号:CA2200324C
公开(公告)日:2008-07-08
申请号:CA2200324
申请日:1996-07-19
Applicant: TORAY INDUSTRIES
Inventor: OHNO HIROSHI , ENDO TAKASHI , IMAMURA YOSHIFUMI , NAGASE HIROSHI
IPC: C07D217/22 , A61K31/472 , A61P11/14 , A61P29/00 , C07D217/16 , C07D405/12
Abstract: 4a-Aryldecahydroisoquinoline compounds typified by the compound of formula (1) or pharmacologically acceptable acid-addition salts thereof. When pharmacologically evaluated in vitro and in vivo, these compounds exhibit an excellent preventive effect on ischemic brain nerve cell necrosis, the effect of inhibiting the progression of cerebral infraction, a potent analgetic effect and an antitussive effect. Thus they are usable in the field of medicines as a brain cell protective agent to be used in order to prevent or treat cerebrovascular disorders, ischemic cerebral disorders, brain nerve cell disorders, dementia, etc., an analgetic agent and an antitussive agent.
-
公开(公告)号:DK0577847T3
公开(公告)日:1999-06-23
申请号:DK93902520
申请日:1993-01-22
Applicant: TORAY INDUSTRIES
Inventor: NAGASE HIROSHI , KAWAI KOJI , ENDO TAKASHI , KAWAMURA KUNIAKI , HAYAKAWA JUN
IPC: C07D333/52 , A61K31/335 , A61K31/35 , A61K31/352 , A61K31/38 , A61K31/381 , A61K31/382 , A61K31/443 , A61K31/4433 , A61K31/445 , A61K31/485 , A61P1/00 , A61P9/00 , A61P43/00 , C07D221/28 , C07D311/80 , C07D313/12 , C07D335/06 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D489/00 , C07D489/08 , A61K31/47 , C07D489/02
Abstract: A morphinan derivative represented by the general formula (I) or its pharmacologically acceptable acid addition salt: wherein R is a specified cyclic ring, B is C1-14 alkylene and A is -XC(=Y)-, -XC(=y)z-, -X-, -XSO2- or -OC(OR )(R )- (where X is NCH3, NH, S or O, but is other than NCH3 when R and R together form -O-, each A, Y and Z, independently, is NR , S or O and R is H, C1-5 alkyl or C6-12 aryl) have analgesic activity.
-
公开(公告)号:DE69414085T2
公开(公告)日:1999-03-18
申请号:DE69414085
申请日:1994-07-19
Applicant: TORAY INDUSTRIES
Inventor: NAGASE HIROSHI , IMAMURA YOSHIFUMI TORAY INDUST , ENDO TAKASHI , MATSUDA SUSUMU TORAY INDUSTRIE , MIYAUCHI YASUSHI TORAY INDUSTR
IPC: A61K31/485 , C07D489/00 , C07D489/08
Abstract: A novel brain cell protective containing a morphinane derivative represented by the compound of formula (1) or a pharmacologically acceptable acid-addition salt thereof as the active ingredient. This compound exhibits an excellent protective effect against cranial nerve cell necrosis in both in vitro and in vivo pharmacological tests, and hence can be used for preventing or treating ischemic encephalopathy, cranial nerve cell disorder, and dementia.
-
公开(公告)号:AT166229T
公开(公告)日:1998-06-15
申请号:AT94903039
申请日:1993-12-22
Applicant: TORAY INDUSTRIES
Inventor: NAGASE HIROSHI , KAMEI JUNZO , KAWAY KOJI , ENDO TAKASHI
IPC: A61K31/485 , A61K31/495 , C07D489/00 , C07D491/18 , C07D491/22
Abstract: An antitussive containing a delta -opioid antagonist or a pharmacologically acceptable salt thereof as the active ingredient. It has a potent activity, does not give side effects such as impaired mentation, and can be administered perorally.
-
公开(公告)号:ES2098357T3
公开(公告)日:1997-05-01
申请号:ES91911488
申请日:1991-06-05
Applicant: TORAY INDUSTRIES
Inventor: NAGASE HIROSHI , MIZUSUNA AKIRA , ONODA YOSHIHIRO , KAWAI KOJI , MATSUMOTO SHU , ENDO TAKASHI
IPC: C07D217/06 , C07D217/24 , C07D471/04 , C07D491/056 , A61K31/475
Abstract: An isoquinoline derivative represented by the general formula (101): wherein R101 is a hydrogen atom or a C1-5 alkyl, C4-7 cycloalkylalkyl, C6-8 cycloalkenylalkyl, C7-14 aralkyl, C4-5 transalkenyl, allyl, furanyl-2-ylalkyl, thienyl-2-ylalkyl or R107OCO group (wherein R107 is a 2,2,2-trichloroethyl or benzyl group) or is a R108CO group (wherein R108 is a C1-5 alkyl, C3-6 cycloalkyl, C5-7 cycloalkenyl, phenyl, C7-13 aralkyl, C4-5 trans-alkenyl, vinyl, 2-furanyl or 2-thienyl group), R102, R103, R104 and R105 are each independently a hydrogen atom or a hydroxy, alkanoyloxy having up to 5 carbon atoms or C1-5 alkoxy group or wherein R102 and R103 jointly or R104 and R105 jointly may form oxo or R103 and R104 jointly may form a 1,3-dioxolan ring, R106 is a hydrogen atom or a hydroxy, C1-5 alkoxy or alkanoyloxy group having up to 5 carbon atoms and wherein the general formula (101) embraces a (+) form, a (-) form, and a (+/-) form, or a pharmacologically acceptable salt thereof; is prepared by oxidizing the carbamate form of an enamine represented by the general formula (103): wherein R102, R103, R104, R105, R106 and R107 are as defined above, thereby forming an oxide represented by the general formula (101a): wherein R102, R103, R104, R105, R106 and R107 are as defined above, and wherein the formula (101a) embraces a (+) form, a (-) form, and a (+/-) form; and optionally converting the group to any of the other values of the group R101. The compounds are intermediates for the production of pharmaceutically useful indole derivatives.
-
公开(公告)号:AU7096096A
公开(公告)日:1997-04-17
申请号:AU7096096
申请日:1996-09-26
Applicant: TORAY INDUSTRIES
Inventor: NAGASE HIROSHI , KAWAI KOJI , ENDO TAKASHI , UENO SHINYA , MAEDA MASAYUKI , SAKAMI SATOSHI
IPC: C07D491/22 , A61K31/475
Abstract: The present invention relates to indole derivatives represented by the following compound 1 and the pharmacologically acceptable acid addition salt thereof. The compounds of the present invention were found to exhibit strong antitussive and analgesic actions as a result of pharmacological evaluation, and can be used in the pharmaceutical field as effective antitussives and analgesics.
-
公开(公告)号:NO943070A
公开(公告)日:1994-10-21
申请号:NO943070
申请日:1994-08-19
Applicant: TORAY INDUSTRIES
Inventor: NAGASE HIROSHI , KAMEI JUNZO , KAWAI KOJI , ENDO TAKASHI
IPC: A61K31/485 , A61K31/495 , C07D489/00 , C07D491/18 , C07D491/22
CPC classification number: A61K31/495 , A61K31/485 , C07D489/00
-
公开(公告)号:FI920480A0
公开(公告)日:1992-02-04
申请号:FI920480
申请日:1992-02-04
Applicant: TORAY INDUSTRIES
Inventor: NAGASE HIROSHI , MIZUSUNA AKIRA , ONODA YOSHIHIRO , KAWAI KOJI , MATSUMOTO SHU , ENDO TAKASHI
IPC: C07D217/06 , C07D217/24 , C07D471/04 , C07D491/056 , C07D
Abstract: An isoquinoline derivative represented by the general formula (101): wherein R101 is a hydrogen atom or a C1-5 alkyl, C4-7 cycloalkylalkyl, C6-8 cycloalkenylalkyl, C7-14 aralkyl, C4-5 transalkenyl, allyl, furanyl-2-ylalkyl, thienyl-2-ylalkyl or R107OCO group (wherein R107 is a 2,2,2-trichloroethyl or benzyl group) or is a R108CO group (wherein R108 is a C1-5 alkyl, C3-6 cycloalkyl, C5-7 cycloalkenyl, phenyl, C7-13 aralkyl, C4-5 trans-alkenyl, vinyl, 2-furanyl or 2-thienyl group), R102, R103, R104 and R105 are each independently a hydrogen atom or a hydroxy, alkanoyloxy having up to 5 carbon atoms or C1-5 alkoxy group or wherein R102 and R103 jointly or R104 and R105 jointly may form oxo or R103 and R104 jointly may form a 1,3-dioxolan ring, R106 is a hydrogen atom or a hydroxy, C1-5 alkoxy or alkanoyloxy group having up to 5 carbon atoms and wherein the general formula (101) embraces a (+) form, a (-) form, and a (+/-) form, or a pharmacologically acceptable salt thereof; is prepared by oxidizing the carbamate form of an enamine represented by the general formula (103): wherein R102, R103, R104, R105, R106 and R107 are as defined above, thereby forming an oxide represented by the general formula (101a): wherein R102, R103, R104, R105, R106 and R107 are as defined above, and wherein the formula (101a) embraces a (+) form, a (-) form, and a (+/-) form; and optionally converting the group to any of the other values of the group R101. The compounds are intermediates for the production of pharmaceutically useful indole derivatives.
-
公开(公告)号:DE60039444D1
公开(公告)日:2008-08-21
申请号:DE60039444
申请日:2000-08-24
Applicant: TORAY INDUSTRIES
Inventor: NAGASE HIROSHI , ENDO TAKASHI , KAWAMURA KUNIAKI , TANAKA TOSHIAKI , SUZUKI TOMOHIKO , SUZUKI TSUTOMU , KURAISHI YASUSHI , SHIRAKI KIMIYASU
IPC: C07D489/06 , A61K31/4738 , A61K31/4745 , A61K31/485 , A61K45/00 , A61P25/04 , C07D471/04 , C07D489/08
Abstract: The present invention relates to a therapeutic agent for neuropathic pain containing, as an active ingredient, a compound represented by general formula (I) or a pharmacologically acceptable acid addition salt thereof: (wherein R , R , R , R , R , R , R , R , A, and B have the same definitions as those described in the specification), and an animal model produced by administering (+)-4a-(3-hydroxyphenyl)-2-methyl-1,2,3,4,4a,5,12,12a-octohydro-trans- quinolinoÄ2,3-gÜisoquinoline. The present invention makes it possible to perform drug treatment for neuropathic pain. The therapeutic effect of a compound against neuropathic pain can also be evaluated.
-
-
-
-
-
-
-
-
-